Posts by: Patricia Silva, PhD

Patricia Silva, PhD

Patrícia holds her PhD in Medical Microbiology and Infectious Diseases from the Leiden University Medical Center in Leiden, The Netherlands. She has studied Applied Biology at Universidade do Minho and was a postdoctoral research fellow at Instituto de Medicina Molecular in Lisbon, Portugal. Her work has been focused on molecular genetic traits of infectious agents such as viruses and parasites.

October 30, 2017October 31, 2017

#MSParis2017 – Aubagio Can Help Slow Progression to an MS Diagnosis, Researcher Says

News

Aubagio (teriflunomide) can help to delay first clinical signs of multiple sclerosis (MS) from progressing to a definite diagnosis in a person, and treatment should likely begin as soon as ... Read more

October 30, 2017October 30, 2017

#MSParis2017 – Promising Work in Pediatric and Secondary Progressive Patients Is Focus, Novartis Says in Interview

News

Gilenya (fingolimod) lowered relapse rates in children and adolescents with relapsing multiple sclerosis at a “magnitude” — almost 82 percent — never before seen in a scientific study and ... Read more

October 27, 2017October 27, 2017

#MSParis2017 – Real-world Data Leading Way to Personalized Treatment, Biogen Says in Interview

News

Personalized medicine is the future of multiple sclerosis treatment, and research now taking place to collect and analyze data and pinpoint biomarkers will help make possible approaches that — ... Read more

October 26, 2017October 26, 2017

#MSParis2017 – Mavenclad Is ‘Smart’ Therapy for Active Relapsing MS, Researcher Says

News

Mavenclad (cladribine tablets), an oral therapy by Merck that’s approved to treat people with active relapsing multiple sclerosis in much of Europe, is a “smart therapy” that is showing real and long-term ... Read more

October 25, 2017October 25, 2017

#MSParis2017 – New Trial of Opicinumab, an Anti-LINGO Antibody, in MS Builds on Lessons Learned, Biogen Says

News

Opicinumab, an investigative treatment aiming to promote remyelination in relapsing multiple sclerosis (MS) patients, will be tested in a new clinical trial — having failed at an earlier effort, ... Read more

June 9, 2016June 9, 2016

#CMSC16 – Metabolism in MS and the Role of Mitochondrial Dysfunction

News

One June 3, a workshop titled “Metabolism in MS and Related Conditions” was presented at the 2016 Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC), held June 1-4 in ... Read more

June 6, 2016June 6, 2016

#CMSC16 – Exclusive Interview with Dr. Rosalind Kalb on MS Care and Family Involvement

News

Dr. Rosalind Kalb, vice president of the Professional Resource Center at the National Multiple Sclerosis Society in New York City, recently presented her work at the 2016 Annual Meeting of the ... Read more

June 3, 2016June 3, 2016

#CMSC16 – Stem Cell Therapy in MS: Exclusive Interview with Dr. Mark Freedman

News

On June 2, a symposium titled “Cell-based therapies in MS” was presented at the 2016 Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC). One of the speakers was ... Read more

June 2, 2016June 2, 2016

#CMSC16 – Lifestyle Factors and Unconventional Medicine in MS Care

News

A symposium focused on lifestyle factors and unconventional medicine as part of the clinical care provided to patients with multiple sclerosis (MS) took place today at the 2016 Annual Meeting of ... Read more

June 1, 2016June 2, 2016

#CMSC16 – MS Expert Fred Lublin Discusses Relevance of MS Relapses

News

Dr. Fred Lublin, a renowned multiple sclerosis (MS) expert at Mount Sinai Medical Center, helped launch the Consortium of Multiple Sclerosis Centers (CMSC) 2016 Annual Meeting, June 1 – 4, in National Harbor, ... Read more

June 1, 2016June 1, 2016

#CMSC16 – Patricia Coyle, an MS Expert, Talks About Vitamin D, Fatigue and Other Key Issues

News

The Consortium of Multiple Sclerosis Centers (CMSC) 2016 Annual Meeting began today, June 1. Multiple Sclerosis News Today is providing extensive on-site coverage of the meeting, reporting on presentations, and conducting exclusive interviews ... Read more

March 21, 2016March 22, 2016

CONy16: Sanofi Genzyme Symposium on MS Therapies Targeting T and B Cells; Exclusive Interview with Lead Researcher

News

Sanofi Genzyme, one of the companies participating in the four-day 10th World Congress on Controversies in Neurology (CONy) in Lisbon, Portugal, that concluded on March 20, 2016, supported several symposiums focused on multiple ... Read more

March 21, 2016March 21, 2016

CONy16: Debate Weighs MS Therapy Risks of Infections Like PML in Terms of Benefits Offered

News

Certain therapies used to treat multiple sclerosis (MS) have been associated with opportunistic infections of the central nervous system, including progressive multifocal leukoencephalopathy (PML), a rare but often fatal brain ... Read more

December 30, 2015December 30, 2015

NIH Grant to Advance Multiple Sclerosis Therapy Targeting Remyelination

News

Novoron Bioscience, Inc., a biotech company focused on developing therapies for disorders of the central nervous system, recently announced that it has received a $680,000 National Institutes of Health ... Read more

December 28, 2015December 28, 2015

New MS Drug Therapy Based on Monomethyl Fumarate Moving Along in Testing

News

Alkermes plc, a biopharmaceutical company focused on therapies for the treatment of central nervous system (CNS) disorders, announced that it has successfully met its 2015 goals for their product ... Read more

December 17, 2015December 17, 2015

New MS Drug Shows ‘Excellent Profile’ in Preclinical Tests Against Approved Therapy

News

Akaal Pharma, a developer of small molecule drugs for the treatment of inflammation and autoimmune diseases including multiple sclerosis (MS), recently announced highly positive preclinical trial results on the ... Read more

December 15, 2015December 15, 2015

MS Nerve Degeneration Triggered by Chain Reaction in Cells

News

Researchers in the United Kingdom recently discovered that a small molecule triggers the destruction of axons, a phenomenon observed in neurodegenerative diseases like multiple sclerosis (MS). The study is titled “Wallerian Degeneration ... Read more

December 14, 2015December 14, 2015

2016 Multiple Sclerosis Forum to Focus on Distinctions in Disease Forms

News

Dr. Jerry S. Wolinsky of the University of Texas in Houston, will give the first Kenneth P. Johnson Memorial Lecture at the opening day of the Americas Committee for the Treatment and ... Read more

December 11, 2015December 11, 2015

Study Recruiting MS Patients to Assess Exercise and Behavioral Therapy

News

Dr. Bradley Bowser, a South Dakota State University (SDSU) researcher and assistant professor, is investigating whether the practice of exercise, either by itself or together with cognitive behavioral therapy, ... Read more

December 10, 2015December 10, 2015

In Multiple Sclerosis Study, Vitamin D Shown to Aid Myelin Repair

News

A new study in the Journal of Cell Biology suggests that vitamin D activates a receptor involved in myelin regeneration in patients with multiple sclerosis (MS). The study, entitled “Vitamin D ... Read more

December 8, 2015December 8, 2015

MS Researchers at Japanese Hospital to Use Novel MRI Technology

News

Juntendo University Hospital, the first medical school in Japan to adopt Western medicine, recently signed a research agreement with SyntheticMR to employ the company’s SyMRI technology in clinical research projects at ... Read more

December 7, 2015December 7, 2015

Relapsing Multiple Sclerosis Treatment Now Available in Japan

News

Takeda Pharmaceutical Co. Ltd., a pharmaceutical company based in Osaka, Japan, recently announced that a widely approved drug treatment for the prevention of relapses in multiple sclerosis (MS) is now available in Japan ... Read more

December 4, 2015December 4, 2015

Brickell Biotech Targeting MS and Other Autoimmune Diseases

News

Brickell Biotech, Inc., a pharmaceutical company developing novel therapies in the field of dermatology, recently announced it has exclusive worldwide rights over a series of new, retinoic acid-related orphan nuclear ... Read more

December 3, 2015December 3, 2015

MS Society of Canada Helps Fund Pediatric Study of Gut Bacteria

News

The Multiple Sclerosis Society of Canada and the Multiple Sclerosis Scientific Research Foundation recently announced the funding of new research on pediatric multiple sclerosis (MS) and on the role ... Read more

December 2, 2015December 2, 2015

Experimental Relapsing-Remitting MS Drug Treatment Advancing

News

Synthetic Biologics, Inc., which specializes in the development of therapies for pathogen-specific diseases, recently announced the publication of new and positive data on results from a Phase 2 clinical trial evaluating ... Read more

December 1, 2015December 1, 2015

National Multiple Sclerosis Society Awards Wisconsin Researcher With Grant To Fuel Promising Study

News

The National Multiple Sclerosis Society awarded a $700,000 research grant to Dr. Bonnie Dittel, Senior Investigator at BloodCenter of Wisconsin (BCW) and adjunct professor at the Medical College of Wisconsin. ... Read more

November 24, 2015November 24, 2015

MS Society Funds 3 New Investigations into Symptom Management

News

The Multiple Sclerosis Society (MS Society) in the U.K. recently announced awards targeted towards new MS research. In total, 16 projects carefully selected by both a panel of experts and patients living ... Read more

November 23, 2015November 23, 2015

MS Society Supports 2 Projects Advancing MS Care, Services

News

The United Kingdom based Multiple Sclerosis Society (MS Society) recently announced £1.98 million in grants to new MS research projects in different disease-related areas. A panel of experts carefully selected 16 ... Read more

November 20, 2015November 20, 2015

MS Society Funds 5 Projects Aiming to Cure the Disease

News

The Multiple Sclerosis Society (MS Society) in the United Kingdom recently announced the investment of £1.98 million in new MS research. After an in-depth, rigorous review process of the ... Read more

November 19, 2015November 19, 2015

MS Society Invests in Research into Underlying Causes of Disease

News

The Multiple Sclerosis Society (MS Society) in the United Kingdom recently announced the investment of £1.98 million in new MS research. The 16 projects awarded funding through the MS ... Read more

November 17, 2015November 17, 2015

Autoimmune Disease Researcher Honored with Sanofi-Institut Pasteur Award

News

Sanofi, a global healthcare leader, and the Institut Pasteur, an internationally renowned center for biomedical research, recently honored four researchers with the Sanofi – Institut Pasteur Awards 2015 for their ... Read more

November 16, 2015November 16, 2015

Mitsubishi Auction Raises Money for Multiple Sclerosis Society

News

Mitsubishi Motors North America, Inc. (MMNA) recently announced a nationwide auction of its first Mitsubishi Lancer Evolution Final Edition to raise money for the National Multiple Sclerosis Society. The auction is ... Read more

November 13, 2015November 13, 2015

MS Patients and Doctors Have a New Way of Working Together

News

A new partnership between ARM and HeartToHeart Networks LLC has brought healthcare providers of patients with neurodegenerative disorders, such as multiple sclerosis, a new and secure tool for remote health management. ... Read more

November 11, 2015November 12, 2015

Roche to Pursue MS Ocrelizumab Drug Market Authorization

News

Roche recently provided an update on their late-stage pipeline products across several therapeutic areas, including ocrelizumab for the treatment of multiple sclerosis. The data was disclosed on Nov. 5 at ... Read more

November 9, 2015November 9, 2015

MS, Other Groups to Benefit from Fitbit’s Step Challenge

News

Fitbit, Inc., a company dedicated to the development of health and fitness products and experiences to help individuals adopt healthier lifestyles, recently announced the FitForGood initiative, a step challenge ... Read more

November 5, 2015November 5, 2015

Autoimmune Disease, Obesity Link Found in Subset of Immune Dendritic Cells

News

In a recent study published in the journal Immunity, researchers at the Weizmann Institute of Science in Israel reported the findings that a small subtype of immune dendritic cells plays ... Read more

November 3, 2015November 3, 2015

Multiple Sclerosis Pilot Study Evaluating PoNS Yields Promising Results

News

Helius Medical Technologies, Inc., a company dedicated to neurological wellness, recently announced that the multiple sclerosis (MS) pilot study assessing the company’s investigational Portable Neuromodulation Stimulator (PoNS™) device has ... Read more

November 2, 2015November 2, 2015

New Muscle Spasticity Therapy Under Priority Review by FDA

News

PathMaker Neurosystems Inc., a clinical-stage neuromodulation company focused on non-invasive therapies for neuromotor disorders, recently announced that the U.S. Food and Drug Administration (FDA) has granted the company’s MyoRegulator™ ... Read more

October 30, 2015October 30, 2015

Overcoming Multiple Sclerosis Group Expands into the United States

News

Overcoming Multiple Sclerosis (OMS), a non-profit organization that promotes a program based on a scientifically tested diet and lifestyle management with the goal of improving the health status and ... Read more

Pin It on Pinterest